Transgenic mouse models of rheumatoid arthritis

Citation
R. Holmdahl et al., Transgenic mouse models of rheumatoid arthritis, IMMUNOL REV, 169, 1999, pp. 161-173
Citations number
83
Categorie Soggetti
Immunology
Journal title
IMMUNOLOGICAL REVIEWS
ISSN journal
01052896 → ACNP
Volume
169
Year of publication
1999
Pages
161 - 173
Database
ISI
SICI code
0105-2896(199906)169:<161:TMMORA>2.0.ZU;2-L
Abstract
A combined analysis of data available in the literature has demonstrated th at the strongest association in rheumatoid arthritis (RA) is with DR genes rather than DQ or DP genes. Functional and structural data of RA-associated DR molecules suggest that selective binding of peptides is the molecular b asis for this association. The establishment of functional transgenic mice expressing RA-associated HLA class II molecules has proven to be useful in the delineation of the role of these molecules in immune responses possibly related to RA and in the development of humanized models for this disease. Such humanized mice develop arthritis upon immunization with type II colla gen (CII), which shows similarities with RA. Interestingly, the immunodomin ant T-cell determinant in CII is derived from positions 261-273, which over lap with a previously identified CII T-cell epitope restricted by the mouse As molecule, which is associated with collagen-induced arthritis. Studies in collagen transgenic mice have shown that recognition of this peptide may lead either to T-cell tolerance or to an arthritogenic response. It is the refore proposed that the T-cell recognition of the CII peptide bound by DR molecules is one of the molecular interactions of critical importance in th e development of RA and accordingly also an important larger for prevention and treatment of this disease.